Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Krista D Kjaergaard

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Clinical Physiology and Functional Imaging|March 26, 2013
Reliability of endogenous markers for estimation of residual renal function in haemodialysis patientsKrista D Kjaergaard, Michael Rehling, Jens D Jensen, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|October 14, 2011
Reliability of ⁵¹Cr-EDTA plasma and urinary clearance as a measure of residual renal function in dialysis patientsKrista D Kjaergaard, Jens D Jensen, Bente Jespersen, et al.
Journal of Hypertension|December 11, 2012
Aortic pulse wave velocity results depend on which carotid artery is used for the measurementsMirela Dzeko, Christian D Peters, Krista D Kjaergaard, et al.
Hemodialysis International. International Symposium on Home Hemodialysis|November 3, 2016
Quality of life development during initial hemodialysis therapy and association with loss of residual renal functionChristina G Poulsen, Krista D Kjaergaard, Christian D Peters, et al.
BMC Nephrology|October 29, 2020
High-sensitivity Troponin T in hemodialysis patients: a randomized placebo-controlled sub-study investigating angiotensin-II-blockade, variation over time and associations with clinical outcomeChristian D Peters, Krista D Kjaergaard, Kent L Christensen, et al.
Hemodialysis International. International Symposium on Home Hemodialysis|June 28, 2016
Long-term effects of angiotensin II blockade with irbesartan on inflammatory markers in hemodialysis patients: A randomized double blind placebo controlled trial (SAFIR study)Christian D Peters, Krista D Kjaergaard, Claus H Nielsen, et al.
Kidney International|July 1, 2015
The Authors ReplyChristian D Peters, Krista D Kjaergaard, Jens D Jensen, et al.
Kidney International|March 28, 2014
No significant effect of angiotensin II receptor blockade on intermediate cardiovascular end points in hemodialysis patientsChristian D Peters, Krista D Kjaergaard, Jens D Jensen, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Clinical Physiology and Functional Imaging|March 26, 2013
Reliability of endogenous markers for estimation of residual renal function in haemodialysis patientsKrista D Kjaergaard, Michael Rehling, Jens D Jensen, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|October 14, 2011
Reliability of ⁵¹Cr-EDTA plasma and urinary clearance as a measure of residual renal function in dialysis patientsKrista D Kjaergaard, Jens D Jensen, Bente Jespersen, et al.
Journal of Hypertension|December 11, 2012
Aortic pulse wave velocity results depend on which carotid artery is used for the measurementsMirela Dzeko, Christian D Peters, Krista D Kjaergaard, et al.
Hemodialysis International. International Symposium on Home Hemodialysis|November 3, 2016
Quality of life development during initial hemodialysis therapy and association with loss of residual renal functionChristina G Poulsen, Krista D Kjaergaard, Christian D Peters, et al.
BMC Nephrology|October 29, 2020
High-sensitivity Troponin T in hemodialysis patients: a randomized placebo-controlled sub-study investigating angiotensin-II-blockade, variation over time and associations with clinical outcomeChristian D Peters, Krista D Kjaergaard, Kent L Christensen, et al.
Hemodialysis International. International Symposium on Home Hemodialysis|June 28, 2016
Long-term effects of angiotensin II blockade with irbesartan on inflammatory markers in hemodialysis patients: A randomized double blind placebo controlled trial (SAFIR study)Christian D Peters, Krista D Kjaergaard, Claus H Nielsen, et al.
Kidney International|July 1, 2015
The Authors ReplyChristian D Peters, Krista D Kjaergaard, Jens D Jensen, et al.
Kidney International|March 28, 2014
No significant effect of angiotensin II receptor blockade on intermediate cardiovascular end points in hemodialysis patientsChristian D Peters, Krista D Kjaergaard, Jens D Jensen, et al.
Pageof 1